DataPile investor atlas

Angel investors & venture capitalists in New Jersey, United States

Last updated 27-10-2025. Data refreshed weekly.

3 Matches for your filters
27 Total investors in region
3,050 Profiles tracked nationwide
27 Based in New Jersey
Princeton (3) Largest investor hub
Princeton Equity Group, HAF Notable firms

Refine investor results

Toggle multiple filters to narrow the directory instantly.

Location

States & regions

Cities

Industry focus

We found 3 investors based in Princeton.

Market intelligence

  • Most active investment themes in New Jersey, United States: venture capital & private equity, mechanical or industrial engineering, information technology & services.
  • 3 profiles are headquartered in Princeton, making it the busiest hub in New Jersey, United States.
  • Featured firms include Princeton Equity Group, HAF, Compucom, Keller Williams Realty, LLC.

Explore states in United States

Showing 1 – 3 of 3 investors

CT
Craig Tillman
Vice President - Investor Services
Brown Brothers Harriman
Focus areas
financial services private banking investment management investor services financial services wealth management asset servicing investment banking private equity commercial banking advisory services global custody securities administration high-net-worth individuals family offices institutional investors capital partner solutions personalized service long-term relationships risk management operational efficiency alternative fund services etf services client success partnership culture sophisticated investors family-owned businesses succession planning technology solutions regulatory compliance client engagement community involvement premium service specialist expertise financial advisory merger and acquisitions trust administration estate planning client-focused approach innovative technology market presence customer loyalty employee satisfaction custody services fund administration securities lending foreign exchange transfer agency regulatory intelligence global markets client experience multi-family office corporate advisory trust services investment strategy endowment management philanthropic advisory values-based wealth planning funding solutions cross-border fund services depositary services alternatives data solutions market insights capital partners financial institutions custom solutions strategic partnerships personalized services expertise and insight long-term investment strategy sustainable investing client-centric approach global reach investment research assets under custody market trends client success stories business continuity planning b2b consulting services capital markets financial consulting management consulting law practice legal services venture capital & private equity
Location
Princeton, New Jersey, United States
Signals
Suketu Desai profile photo Bristol Myers Squibb logo
Suketu Desai
Director - Investor Relations
Bristol Myers Squibb
Focus areas
pharmaceuticals biotechnology innovation great place to work pharmaceuticals research & development healthcare health & wellness life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech r&d patient-centered b2b biotech research advances acute coronary syndrome pharmaceutical innovation clinical research biotech in inflammatory diseases atrial fibrillation blockbuster drugs immunology government biotech research platforms pharmaceutical and medicine manufacturing biotech innovation hubs cardiovascular blood clotting market leadership biotech in cancer patient resources drug discovery market access research and development healthcare providers oncology biotech manufacturing oncology drugs fibrosis treatments biotech innovation platforms therapeutics secondary stroke prevention fibrosis biotech innovation partnerships risk management biologics biotech clinical development cancer immunotherapy biotech research investments global reach financial reporting biotech partnerships biotech pipeline biopharma biotech research programs biopharmaceutical biotech innovation ecosystem biotech innovation research facilities biotech collaborations biotech in genetic disorders biotech innovation strategies cancer immunotherapy drugs oncology pipeline precision medicine immune system biotech in cardiovascular drug development biotech in neuroscience services innovative medicines biotech research centers biologics manufacturing biotech research initiatives pipeline biotech in metabolic diseases immunology pipeline biotech phase 3 clinical trials biotech in fibrosis biotech in rare diseases global healthcare clinical trials marketed drugs biotech in autoimmune diseases milvexian biotech research collaborations immunotherapy biotech research projects biotech research pipelines biotech research funding targeted therapies cancer therapy medical research neuroscience portfolio biotech research breakthroughs biotech pipeline management blood clotting disorders blood thinners cell therapy car t cell therapy cancer treatment translational medicine health equity licensed agreements generic drugs drug pricing scientific research clinical trial access disease research patient-centered care global health therapeutic areas research pipeline investors corporate responsibility disease state resources global partnerships medical information pediatric implications chronic diseases emergency protocols post-study access prescription assistance stem education community impact environmental sustainability inclusion and diversity corporate governance transparency initiatives shareholder services analyst coverage stakeholder engagement manufacturing distribution medical health wellness & fitness hospital & health care mechanical or industrial engineering
Location
Princeton, New Jersey, United States
Signals

Explore other regions in United States